Introduction Cardiac resynchronization defibrillator (CRT‐D) as primary prevention is known
to reduce mortality. At the time of replacement, higher age and comorbidities may attenuate …

Background The beneficial effects of a cardiac resynchronization defibrillator (CRT-D) in
patients with heart failure, low left ventricular ejection fraction (LVEF), and wide QRS have …

Background Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in
selected heart failure patients, but decision-making regarding selection of CRT-defibrillator …

Background In patients with cardiac resynchronization therapy defibrillators (CRT-Ds), the
need for implantable cardioverter-defibrillator (ICD) back-up may be questionable at time of …

Aims To assess and compare long-term mortality and predictors thereof in de novo cardiac
resynchronization therapy defibrillators (CRT-D) vs. upgrade from an implantable …

Aims Comorbidity, such as myocardial infarction, diabetes, and renal failure, plays a pivotal
role in the prognosis of a patient with arrhythmias. However, data on the prognostic impact of …

Background Registry data add important information to randomized controlled trials (RCT)
on real‐life aspects of implantable cardioverter‐defibrillator (ICD) patients with and without …

Background Panoramic studies in patients with cardiac resynchronization therapy with a
defibrillator (CRT‐D) focusing on the etiology and indication are scarce. Besides, a …

Background Risk-benefit for cardiac resynchronisation therapy (CRT) defibrillator (CRT-D)
over CRT pacemaker remains a matter of debate. We aimed to identify patients with a poor …

Background: The utilization of cardiac resynchronization therapy defibrillator (CRT‐D) has
increased significantly, since its initial approval for use in selected patients with heart failure …